NCT02143856View on ClinicalTrials.gov

Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Healthy

Interventions

DRUG

100 mg GLPG1205

A single dose of 100 mg GLPG1205 administered as two capsules of 50 mg

Trial Locations (1)

Unknown

SGS LSS Clinical Pharmacology Unit Antwerp, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY

NCT02143856 - Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food | Biotech Hunter | Biotech Hunter